Literature DB >> 12220351

Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.

Agnes Bánkfalvi1, Melanie Krassort, András Végh, Endre Felszeghy, Jozsef Piffkó.   

Abstract

BACKGROUND: Deranged expression and function of the E-cadherin/beta-catenin (E-cad/beta-cat) complex and the epidermal growth factor receptor (EGFR) have been implicated in the development and progression of carcinomas.
METHODS: To estimate the role of these molecules in oral cancer, we investigated 75 primary oral squamous cell carcinomas (OSCCs) with adjacent normal and/or dysplastic mucosa, 30 paired metastases and 12 recurrences by immunohistochemistry.
RESULTS: All three molecules were constitutionally expressed in the basal/parabasal layers of tumour adjacent 'normal' epithelium, in contrast to a significant increase of EGFR and heterogeneous expression of E-cad/beta-cat in dysplasia. In OSCCs, over-expression of EGFR correlated significantly with lower tumour grade and poor prognosis, loss of E-cad was a significant marker for shortened survival, reduced beta-cat staining was a predictive marker for lymph node metastasis.
CONCLUSIONS: There is a perturbance in intercellular adhesion molecules and EGFR expression/function in oral cancer with major clinical impact. E-cad and beta-cat seem to inhibit EGFR to enhance the progression of OSCCs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220351     DOI: 10.1034/j.1600-0714.2002.00147.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  20 in total

1.  Assessment of CTNNB1 gene mutations and β-catenin immunoexpression in salivary gland pleomorphic adenomas and adenoid cystic carcinomas.

Authors:  Roberta Barroso Cavalcante; Cassiano Francisco Weege Nonaka; Hellen Bandeira de Pontes Santos; Silvia Helena Barem Rabenhorst; Leão Pereira Pinto; Lélia Batista de Souza
Journal:  Virchows Arch       Date:  2018-03-26       Impact factor: 4.064

2.  Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis.

Authors:  Xin Zhang; Ling Su; Ali A Pirani; Haiyan Wu; Hongzheng Zhang; Dong M Shin; Kim M Gernert; Zhuo Georgia Chen
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

3.  Immunohistochemical Expression of the Epithelial to Mesenchymal Transition Proteins E-cadherin and ß-catenin in Grades of Oral Squamous Cell Carcinoma.

Authors:  Vijay Kumar; Abikshyeet Panda; Kailash Chandra Dash; Lipsa Bhuyan; Niva Mahapatra; Pallavi Mishra
Journal:  J Pharm Bioallied Sci       Date:  2021-06-05

Review 4.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

Review 5.  Glycogen synthase kinase 3 beta: can it be a target for oral cancer.

Authors:  Rajakishore Mishra
Journal:  Mol Cancer       Date:  2010-06-11       Impact factor: 27.401

Review 6.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

Review 7.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

8.  Prognostic significance of E-Cadherin, β-Catenin and cyclin D1 in oral squamous cell carcinoma: a tissue microarray study.

Authors:  Natheer Al-Rawi; Muwaffaq Al Ani; Asif Quadri; Zaid Hamdoon; Aktham Awwad; Sausan Al Kawas; Ahmed Al Nuaimi
Journal:  Histol Histopathol       Date:  2021-07-26       Impact factor: 2.303

9.  The Expression of Selected Wnt Pathway Members (FZD6, AXIN2 and β-Catenin) in Canine Oral Squamous Cell Carcinoma and Acanthomatous Ameloblastoma.

Authors:  Barbora Putnová; Iveta Putnová; Miša Škorič; Marcela Buchtová
Journal:  Animals (Basel)       Date:  2021-05-29       Impact factor: 2.752

10.  Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.

Authors:  Jatinder Kaur; Meenakshi Sawhney; Siddhartha DattaGupta; Nootan Kumar Shukla; Anurag Srivastava; Paul G Walfish; Ranju Ralhan
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.